A wide-ranging group of chemicals generally referred to as “emerging contaminants” have been found increasingly in waterways, drinking water systems, and upland environments, raising concerns about human and environmental safety. They include pharmaceuticals, chemicals in personal and consumer products, and industrial and agricultural chemicals.
Because knowledge about the toxicology, epidemiology, fate, and treatment of these compounds and the rules regulating them are evolving, our clients are faced with managing risks in a rapidly changing world.
We help our clients track emerging contaminant (EC) science and regulations and develop effective risk management strategies to mitigate impacts from emerging contaminants on their businesses. We help our clients remain compliant with dynamic requirements and be good environmental and public health stewards.
We work with clients to design and implement strategies that reflect the latest technical knowledge and regulatory contexts. Our staff contribute to state-of-the-science approaches and research, participate on advisory boards, and lead workshops on topics involving emerging contaminants. We advise clients on ways to assess and minimize potential liabilities and offer insight on methods to conduct and streamline evaluations.
Our engineers have performed treatment technology evaluations for 1,4-dioxane, PFAS, 1,2,3-TCP, and other emerging contaminants. We are experienced in the evaluation of technology effectiveness, implementability, and cost. We have completed numerous remediation system designs, including those for potable water treatment systems.
FATE AND TRANSPORT
We extend our expertise in chemical fate and transport to a range of emerging contaminants, including PFAS, sulfolane, 1,4-dioxane, 1,2,3-TCP, organic acids, and other emerging contaminantsto support litigation, assessment of human health risk issues, remedial investigations, and design of site-specific risk management and remediation strategies. Central to our approach is developing accurate and robust conceptual site models using multiple lines of evidence. Our approach allows us to negotiate remedies and risk mitigation plans based on defensible science.
FEATURED STAFF MEMBER
Avram Frankel, P.E.
Mr. Avram Frankel is a program manager with nearly 30 years of experience working on a wide range of commercial/industrial, municipal, state, and federal sites regulated under a variety of regulatory programs. Licensed in four states, he provides clients with strategic management and technical analysis of due diligence, redevelopment, technology evaluation, remediation, and litigation matters.
recent news and articles
Are you interested in Florida’s coastal resources? Then check out the Florida Coastal Mapping Program’s (FCMaP) online summit on December 7, 2021! This free event will feature discussions on coastal mapping updates, priorities, technology specs and standards, and information about the newly funded Florida Seafloor Mapping Initiative. The summit will include presentations from federal, state, and academic partners. Integral Senior Consultant Cheryl Hapke, Ph.D., is a cofounder of FCMaP and has served as its coordinator, and now chair, since 2018.
Katherine Heal Contributes to New Study on Arsenic and Lipids Featured in Chemical & Engineering News
Integral scientist Katherine Heal, Ph.D., contributes her insights and research on arsenic to the article “Bacteria incorporate arsenic into lipids” in the November 8, 2021, issue of Chemical & Engineering News. The article features results of a study Dr. Heal...
Integral scientists Christina Ross and Paul DeLeo, Ph.D., are coauthors of an article titled “Benzene in Sunscreens & Sun Care Products,” published in the November issue of the trade magazine Happi. In light of recent media coverage on low levels of benzene detected in several sunscreen products, the article examines dermal exposure to benzene from topically applied consumer products.